Skip to main content
. 2012 May 30;303(3):F350–F356. doi: 10.1152/ajprenal.00077.2012

Fig. 6.

Fig. 6.

CaMKIIδ antagonist reduces pelvic allodynia. Mice were infected with PRV and then treated intrathecally with KN-92 (A) or KN-93 (B) (n = 6 mice). Pelvic allodynia was assessed before and 1 h after intrathecal treatment. C: mice treated with KN-93 exhibited significantly diminished pelvic allodynia relative to mice treated with KN-92. Values are means ± SE. *P < 0.05.

HHS Vulnerability Disclosure